NEW YORK, NY, Jan. 10, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Tauriga Sciences, Inc.¬†(TAUG) (...
Tauriga ready to launch CBD Tauri-GUM
CBD TAURI-GUM IS ONE OF TAURIGA’S FIRST GUM PRODUCTS
Tauriga Sciences would like to thank all its loyal shareholders as well as welcome new shareholders. Management believes 2019 will be an exciting turnaround year for the Company. Since¬†the Company¬†settled¬†its¬†lawsuit with¬†its¬†previous¬†auditor¬†Management¬†has been diligently¬†working¬†on creating¬†value¬†for the Company and¬†the¬†Company’s shareholders.
The Company has previously indicated in press releases the intent to pursue M&A but the Company has also taken equity positions in several¬†companies¬†that¬†could have tremendous¬†returns.¬† In December¬†2018 the¬†Company¬†decided¬†to launch Tauri-GUM.¬† Tauri-GUM¬†is¬†a gum¬†that¬†contains¬†CBD. The¬†process is¬†patented. This is the¬†first¬†of¬†several¬†products the Company¬†is set¬†to launch.
The Company is also exploring purchasing a California based Omega – 3 Company and has entered into a¬†Memorandum of Understanding to acquire¬†the¬†product as well as the technology. Subsequent to¬†the¬†Company¬†negotiating¬†the¬†MOU a publically traded Company Amarin¬†had¬†successful trials¬†with its¬†Omega-3 product¬†which was recognized¬†by the FDA.
The Company is aggressively pursuing other revenue and asset building opportunities. The Company believes wholeheartedly that 2019 will mark a major turn around¬†for¬†Tauriga¬†shareholders and will¬†be¬†providing updates¬†via¬†press releases and¬†interviews¬†throughout the¬†year.
NEW YORK, NY, Jan. 10, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Tauriga Sciences, Inc.¬†(TAUG) (‚ÄúTauriga‚ÄĚ or the ‚ÄúCompany‚ÄĚ), eng...Read More
NEW YORK, NY, Jan. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (TAUG) (‚ÄúTauriga‚ÄĚ or the ‚ÄúCompany‚ÄĚ), enga...Read More
New York, NY, Jan. 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (TAUG) (‚ÄúTauriga‚ÄĚ or the ‚ÄúCompany‚ÄĚ), enga...Read More
Fully committed to commercializing innovation to enhance personal wellness, improve our environment and create lasting shareholder value.